Latest News and Press Releases
Want to stay updated on the latest news?
-
EUR 1.2 million in equity and EUR 0.8 million by means of a convertible loan note Zutphen, The Netherlands - 26 May 2015 ESPERITE announces an agreement with Educe Capital (Malta), a financial...
-
EUR 1.2 million in equity and EUR 0.8 million by means of a convertible loan note Zutphen, The Netherlands - 26 May 2015 ESPERITE announces an agreement with Educe Capital (Malta), a financial...
-
The company is now building the future. CryoSave is on track and Genoma shows its ability to support the current published forecasts and ambitious next developments. Zutphen, The...
-
The company is now building the future. CryoSave is on track and Genoma shows its ability to support the current published forecasts and ambitious next developments. Zutphen, The...
-
Zutphen, the Netherlands - 6 May 2015 Esperite N.V. announces that it has convened its Annual General Meeting of Shareholders ("AGM") to be held on Wednesday 17 June 2015. At the AGM, the...
-
Zutphen, Les Pays Bas- le 6 mai 2015 Esperite NV annonce qu'elle a lancé les convocations pour son Assemblée Générale Annuelle des Actionnaires ("AGA") qui se tiendra le mercredi 17 Juin 2015....
-
Zutphen, The Netherlands - 1 May 2015 ESPERITE has published today its Annual Report for the year ended 31st December 2014. The 2014 Annual Report is now available on the Company's website...
-
Zutphen, Hollande - 1 mai 2015 ESPERITE a publié aujourd'hui son rapport annuel pour l'exercice clos le 31 Décembre 2014. Le rapport annuel 2014 est maintenant disponible sur le site Web de la...
-
TRANQUILITY, the only CE-IVD certified genetic test for trisomies 21, 18 and 13 that provides, sexual aneuploidies, microdeletions and fetal sex detection, now ready for mass market ...
-
A mindenki számára elérhető TRANQUILITY, az egyetlen CE-IVD jelzéssel ellátott genetikai teszt a 21-es, a 18-as és a 13-as triszómiák, a nemi kromoszóma aneuploidiák, a mikrodeléciók kimutatására,...